Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Assets Average (2018 - 2025)

Historic Assets Average for Arcus Biosciences (RCUS) over the last 8 years, with Q3 2025 value amounting to $1.0 billion.

  • Arcus Biosciences' Assets Average fell 1804.0% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 1804.0%. This contributed to the annual value of $1.1 billion for FY2024, which is 626.3% down from last year.
  • Per Arcus Biosciences' latest filing, its Assets Average stood at $1.0 billion for Q3 2025, which was down 1804.0% from $1.1 billion recorded in Q2 2025.
  • Over the past 5 years, Arcus Biosciences' Assets Average peaked at $1.6 billion during Q1 2022, and registered a low of $853.7 million during Q1 2021.
  • Moreover, its 5-year median value for Assets Average was $1.2 billion (2021), whereas its average is $1.2 billion.
  • Per our database at Business Quant, Arcus Biosciences' Assets Average surged by 35020.25% in 2021 and then crashed by 1854.38% in 2023.
  • Quarter analysis of 5 years shows Arcus Biosciences' Assets Average stood at $1.2 billion in 2021, then rose by 10.8% to $1.3 billion in 2022, then fell by 15.14% to $1.1 billion in 2023, then grew by 7.17% to $1.2 billion in 2024, then dropped by 16.37% to $1.0 billion in 2025.
  • Its Assets Average stands at $1.0 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $1.2 billion for Q1 2025.